ARTES Biotechnology GmbH

ARTES Biotechnology GmbH is a globally active R&D company that has been specializing in developing biopharmaceutical production processes since 2002. The company has positioned itself as a valuable partner for the pharmaceutical industry by offering proprietary expression systems and expertise from cell line development to manufacturing. They have successfully implemented several technology transfers worldwide at clients'​ sites. ARTES is a well-established partner for the development of customer-driven projects and has the capability to supply pre-clinical material. In addition, the company is also involved in developing its own virus-like particle (VLP) based vaccine candidates up to proof-of-concept in animals. Based in Germany, ARTES Biotechnology operates in the Biotechnology and Pharmaceutical industries. Currently, there is no publicly available information about their last investment or the investors involved.